Literature DB >> 21092834

Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing.

Xiao-Kang Zheng1, Long-Hua Chen, Wen-Jun Wang, Feng Ye, Jia-Bing Liu, Qi-Sheng Li, Hen-Wen Sun.   

Abstract

PURPOSE: To determine the impact of prolonged fraction delivery times (FDTs) simulating intensity-modulated radiotherapy (IMRT) on cultured nasopharyngeal carcinoma (NPC) cell killing. METHODS AND MATERIAL: Cultured NPC cell lines CNE1 and CNE2 were used in this study. The biological effectiveness of fractionated irradiation protocols simulating conventional external beam radiotherapy and IMRT (FDT of 15, 36, and 50 minutes) was estimated with standard colony assay, and the differences in cell surviving fractions after irradiation with different protocols were tested by use of the paired t test. The impact degree of prolonged FDTs (from 8 to 50 minutes) on cell killing was also assessed by the dose-modifying factors, which were estimated by comparing the effectiveness of intermittently delivered 2 Gy with that of continuously delivered 1.5 to 2 Gy.
RESULTS: The cell surviving fractions of both CNE1 and CNE2 after fractionated irradiation simulating IMRT were higher than those simulating conventional external beam radiotherapy (p < 0.05). The dose-modifying factors for a fraction dose of 2 Gy increased from 1.05 to 1.18 for CNE1 and from 1.05 to 1.11 for CNE2 with the FDT being prolonged from 15 to 50 minutes.
CONCLUSIONS: This study showed that the prolonged FDTs simulating IMRT significantly decreased the cell killing in both CNE1 and CNE2 cell lines, and these negative effects increased with the FDT being prolonged from 15 to 50 minutes. These effects, if confirmed by in vivo and clinical studies, need to be considered in designing IMRT treatments for NPC.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21092834     DOI: 10.1016/j.ijrobp.2010.07.005

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  The potential of helical tomotherapy in the treatment of head and neck cancer.

Authors:  Dirk Van Gestel; Dirk Verellen; Lien Van De Voorde; Bie de Ost; Geert De Kerf; Olivier Vanderveken; Carl Van Laer; Danielle Van den Weyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Oncologist       Date:  2013-05-30

2.  SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Authors:  J Gao; T-L Qian; C-Z Tao; Y-H Zhang; Y Zhou; J Yang; J He; R Wang; P-J Zhou
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

Review 3.  Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.

Authors:  M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni
Journal:  Clin Transl Oncol       Date:  2019-06-28       Impact factor: 3.405

4.  Combined paclitaxel, cisplatin and fluorouracil therapy enhances ionizing radiation effects, inhibits migration and induces G0/G1 cell cycle arrest and apoptosis in oral carcinoma cell lines.

Authors:  Silvia Taveira Elias; Gabriel Alvares Borges; Daniela Fortunato Rêgo; Luis Felipe Oliveira E Silva; Samuel Avelino; João Nunes DE Matos Neto; Luiz Alberto Simeoni; Eliete Neves Silva Guerra
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

5.  Coplanar VMAT vs. noncoplanar VMAT in the treatment of sinonasal cancer.

Authors:  Ning Zhong-Hua; Jiang Jing-Ting; Li Xiao-Dong; Mu Jin-Ming; Mo Jun-Chong; Jin Jian-Xue; Gao Ming; Li Qi-Lin; Gu Wen-Dong; Chen Lu-Jun; Pei Hong-Lei
Journal:  Strahlenther Onkol       Date:  2014-10-08       Impact factor: 3.621

6.  Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Yunbao Pan; Qingxiu Zhang; Ling Tian; Xin Wang; Xiaohang Fan; Huizhong Zhang; Francois X Claret; Huiling Yang
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

7.  RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison.

Authors:  Dirk Van Gestel; Corine van Vliet-Vroegindeweij; Frank Van den Heuvel; Wouter Crijns; Ann Coelmont; Bie De Ost; Andrea Holt; Emmy Lamers; Yasmyne Geussens; Sandra Nuyts; Danielle Van den Weyngaert; Tim Van den Wyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Radiat Oncol       Date:  2013-02-20       Impact factor: 3.481

8.  Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy.

Authors:  Qiwei Yao; Rong Zheng; Guozhu Xie; Guixiang Liao; Shasha Du; Chen Ren; Rong Li; Xiaoshan Lin; Daokun Hu; Yawei Yuan
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

9.  Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless?

Authors:  Dirk Van Gestel; Geert De Kerf; Kristien Wouters; Wouter Crijns; Jan B Vermorken; Vincent Gregoire; Dirk Verellen
Journal:  Radiat Oncol       Date:  2015-12-23       Impact factor: 3.481

10.  Enhanced inhibitory effect of curcumin via reactive oxygen species generation in human nasopharyngeal carcinoma cells following purple-light irradiation.

Authors:  Dujuan Wang; Jiang Hu; Lin Lv; Xiuwen Xia; Jianzhong Liu; Xiaoyuan Li
Journal:  Oncol Lett       Date:  2013-05-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.